These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17458552)

  • 1. The neuropathology and clinical phenotype of FTD with progranulin mutations.
    Mackenzie IR
    Acta Neuropathol; 2007 Jul; 114(1):49-54. PubMed ID: 17458552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic correlation in PGRN mutations.
    Davion S; Johnson N; Weintraub S; Mesulam MM; Engberg A; Mishra M; Baker M; Adamson J; Hutton M; Rademakers R; Bigio EH
    Neurology; 2007 Sep; 69(11):1113-21. PubMed ID: 17522386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.
    Snowden JS; Pickering-Brown SM; Mackenzie IR; Richardson AM; Varma A; Neary D; Mann DM
    Brain; 2006 Nov; 129(Pt 11):3091-102. PubMed ID: 17003069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
    Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
    Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.
    Mackenzie IR; Baker M; Pickering-Brown S; Hsiung GY; Lindholm C; Dwosh E; Gass J; Cannon A; Rademakers R; Hutton M; Feldman HH
    Brain; 2006 Nov; 129(Pt 11):3081-90. PubMed ID: 17071926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features of frontotemporal dementia with progranulin sequence variation.
    Spina S; Murrell JR; Huey ED; Wassermann EM; Pietrini P; Baraibar MA; Barbeito AG; Troncoso JC; Vidal R; Ghetti B; Grafman J
    Neurology; 2007 Mar; 68(11):820-7. PubMed ID: 17202431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.
    López de Munain A; Alzualde A; Gorostidi A; Otaegui D; Ruiz-Martínez J; Indakoetxea B; Ferrer I; Pérez-Tur J; Sáenz A; Bergareche A; Barandiarán M; Poza JJ; Zabalza R; Ruiz I; Urtasun M; Fernández-Manchola I; Olasagasti B; Espinal JB; Olaskoaga J; Ruibal M; Moreno F; Carrera N; Martí Massó JF
    Biol Psychiatry; 2008 May; 63(10):946-52. PubMed ID: 17950702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
    Josephs KA; Ahmed Z; Katsuse O; Parisi JF; Boeve BF; Knopman DS; Petersen RC; Davies P; Duara R; Graff-Radford NR; Uitti RJ; Rademakers R; Adamson J; Baker M; Hutton ML; Dickson DW
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):142-51. PubMed ID: 17278999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
    Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
    Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.
    Baker M; Mackenzie IR; Pickering-Brown SM; Gass J; Rademakers R; Lindholm C; Snowden J; Adamson J; Sadovnick AD; Rollinson S; Cannon A; Dwosh E; Neary D; Melquist S; Richardson A; Dickson D; Berger Z; Eriksen J; Robinson T; Zehr C; Dickey CA; Crook R; McGowan E; Mann D; Boeve B; Feldman H; Hutton M
    Nature; 2006 Aug; 442(7105):916-9. PubMed ID: 16862116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
    Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.
    Mackenzie IR; Rademakers R
    Neurogenetics; 2007 Nov; 8(4):237-48. PubMed ID: 17805587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of frontotemporal dementia.
    Neumann M; Tolnay M; Mackenzie IR
    Expert Rev Mol Med; 2009 Jul; 11():e23. PubMed ID: 19638255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
    Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.
    Mukherjee O; Wang J; Gitcho M; Chakraverty S; Taylor-Reinwald L; Shears S; Kauwe JS; Norton J; Levitch D; Bigio EH; Hatanpaa KJ; White CL; Morris JC; Cairns NJ; Goate A
    Hum Mutat; 2008 Apr; 29(4):512-21. PubMed ID: 18183624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations.
    Seelaar H; Schelhaas HJ; Azmani A; Küsters B; Rosso S; Majoor-Krakauer D; de Rijk MC; Rizzu P; ten Brummelhuis M; van Doorn PA; Kamphorst W; Willemsen R; van Swieten JC
    Brain; 2007 May; 130(Pt 5):1375-85. PubMed ID: 17360763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.
    Cruts M; Kumar-Singh S; Van Broeckhoven C
    Curr Alzheimer Res; 2006 Dec; 3(5):485-91. PubMed ID: 17168647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal lobar degeneration: clinical and pathological relationships.
    Snowden J; Neary D; Mann D
    Acta Neuropathol; 2007 Jul; 114(1):31-8. PubMed ID: 17569065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.